Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Growing demand for immuno-oncology therapies
3.2.1.2 Advancements in in-vivo models
3.2.1.3 Growing investments in precision oncology
3.2.1.4 Growing oncology drug approvals from small biotechnology and pharmaceutical companies
3.2.2 Industry pitfalls & challenges
3.2.2.1 Stringent regulatory requirements for oncology drug approvals
3.2.2.2 Presence of strong alternatives
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technological landscape
3.6 Patent Analysis
3.7 Future market trends
3.8 Porter’s analysis
3.9 PESTEL analysis
Chapter 4 Competitive Landscape, 2024
4.1 Introduction
4.2 Company market share analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy outlook
Chapter 5 Market Estimates and Forecast, By Service, 2021 – 2034 ($ Mn)
5.1 Key trends
5.2 Preclinical testing
5.3 Efficacy testing
5.4 Toxicology studies
5.5 Pharmacokinetics
5.6 Other services
Chapter 6 Market Estimates and Forecast, By Model, 2021 – 2034 ($ Mn)
6.1 Key trends
6.2 Xenograft
6.2.1 Patient derived xenograft
6.2.2 Cell-line derived xenograft
6.2.3 Other xenografts
6.3 Syngeneic
6.4 Other models
Chapter 7 Market Estimates and Forecast, By End Use, 2021 – 2034 ($ Mn)
7.1 Key trends
7.2 Pharmaceutical companies
7.3 Biotechnology companies
7.4 Other end users
Chapter 8 Market Estimates and Forecast, By Region, 2021 – 2034 ($ Mn)
8.1 Key trends
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.6 Middle East and Africa
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 UAE
Chapter 9 Company Profiles
9.1 Charles River Laboratories
9.2 Crown Bioscience
9.3 Eurofins Scientific
9.4 Evotec SE
9.5 ICON plc
9.6 IMV
9.7 Laboratory Corporation of America Holdings
9.8 Medidata
9.9 Merck KGaA
9.10 OncoOne
9.11 Pharmaron
9.12 Taconic Biosciences
9.13 The Jackson Laboratory
9.14 Thermo Fisher Scientific
9.15 WuXi AppTec
